Anixa Biosciences
(NASDAQ:ANIX)
$3.17
0.01[0.32%]
At close: Apr 16
$3.21
0.0400[1.26%]
After Hours: 8:31AM EDT
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Anixa Biosciences Stock (NASDAQ:ANIX), Quotes and News Summary

Anixa Biosciences Stock (NASDAQ: ANIX) stock price, news, charts, stock research, profile.

Open$3.170
Close-
Volume / Avg.78.203K / 138.830K
Day Range3.150 - 3.250
52 Wk Range2.750 - 6.450
Market Cap$101.122M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
43
Short Interest
3.02%
Days to Cover3.76

Recent News

Sponsored
Anixa Biosciences, A New Type Of Biotech Company: Could It Disrupt The Cancer Landscape?
Anixa Biosciences (NASDAQ: ANIX) is an interesting, undiscovered biotech company that seeks to disrupt the cancer landscape by working with some highly credible partners. The company is undiscovered for many reasons including its history.
Anixa Biosciences Reveals Updated Data From Breast Cancer Vaccine Trial, Says 'Exceeded Expectations'
Anixa Biosciences Inc (NASDAQ: ANIX) announced new and updated results from the Phase 1 trial of its breast cancer vaccine. 
Vandana Singh
Sponsored
Could Anixa Biosciences (NASDAQ: ANIX) Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer?
Cancer is a disease that affects millions of people around the world. Historically, cancer vaccines have not been very successful in treating or preventing the disease. However, recent research on the human immune system has led to the development of innovative immuno-therapy drugs that have been approved and commercialized.
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Dec 23
1
Feb
1
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Anixa Biosciences Inc
Sector
Health Care
Industry
Biotechnology
Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies tha...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ANIX
CNTB

FAQ

Q

How do I buy Anixa Biosciences (ANIX) stock?

A

You can purchase shares of Anixa Biosciences (NASDAQ: ANIX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Anixa Biosciences's (ANIX) competitors?

A

Other companies in Anixa Biosciences’s space includes: Connect Biopharma Hldgs (NASDAQ:CNTB), Cellectar Biosciences (NASDAQ:CLRB), Curis (NASDAQ:CRIS), Armata Pharmaceuticals (AMEX:ARMP) and Barinthus Biotherapeutics (NASDAQ:BRNS).

Q

What is the target price for Anixa Biosciences (ANIX) stock?

A

The latest price target for Anixa Biosciences (NASDAQ: ANIX) was reported by HC Wainwright & Co. on Thursday, March 21, 2024. The analyst firm set a price target for 12.00 expecting ANIX to rise to within 12 months (a possible 273.83% upside). 11 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Anixa Biosciences (ANIX)?

A

The stock price for Anixa Biosciences (NASDAQ: ANIX) is $3.21 last updated April 12, 2024 at 8:31 AM EDT.

Q

Does Anixa Biosciences (ANIX) pay a dividend?

A

There are no upcoming dividends for Anixa Biosciences.

Q

When is Anixa Biosciences (NASDAQ:ANIX) reporting earnings?

A

Anixa Biosciences’s Q2 earnings are confirmed for Wednesday, June 12, 2024.

Q

Is Anixa Biosciences (ANIX) going to split?

A

There is no upcoming split for Anixa Biosciences.

Q

What sector and industry does Anixa Biosciences (ANIX) operate in?

A

Anixa Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch